 Dose-Response Relationship, Drug
"Dose-Response Relationship, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relationship between the dose of an administered drug and the response of the organism to the drug.
| Descriptor ID |
D004305
|
| MeSH Number(s) |
G07.690.773.875 G07.690.936.500
|
| Concept/Terms |
Dose-Response Relationship, Drug- Dose-Response Relationship, Drug
- Dose-Response Relationships, Drug
- Drug Dose-Response Relationship
- Drug Dose-Response Relationships
- Relationship, Drug Dose-Response
- Relationships, Drug Dose-Response
- Dose Response Relationship, Drug
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Drug".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Drug".
This graph shows the total number of publications written about "Dose-Response Relationship, Drug" by people in this website by year, and whether "Dose-Response Relationship, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 17 | 17 | | 1997 | 0 | 31 | 31 | | 1998 | 0 | 20 | 20 | | 1999 | 0 | 23 | 23 | | 2000 | 0 | 32 | 32 | | 2001 | 0 | 42 | 42 | | 2002 | 0 | 50 | 50 | | 2003 | 0 | 62 | 62 | | 2004 | 0 | 65 | 65 | | 2005 | 0 | 66 | 66 | | 2006 | 1 | 60 | 61 | | 2007 | 0 | 72 | 72 | | 2008 | 0 | 85 | 85 | | 2009 | 0 | 70 | 70 | | 2010 | 0 | 61 | 61 | | 2011 | 0 | 66 | 66 | | 2012 | 0 | 68 | 68 | | 2013 | 0 | 57 | 57 | | 2014 | 0 | 86 | 86 | | 2015 | 0 | 73 | 73 | | 2016 | 0 | 67 | 67 | | 2017 | 1 | 75 | 76 | | 2018 | 0 | 52 | 52 | | 2019 | 0 | 50 | 50 | | 2020 | 0 | 37 | 37 | | 2021 | 0 | 24 | 24 | | 2022 | 0 | 5 | 5 | | 2023 | 1 | 2 | 3 | | 2024 | 0 | 19 | 19 | | 2025 | 0 | 13 | 13 | | 2026 | 0 | 11 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Dose-Response Relationship, Drug" by people in Profiles.
-
April MD, Butler H, Demasi SC, Aggarwal NR, Andrea LJ, Barker AB, Barnes CR, Brainard JC, Brewer JM, Driver BE, Gaillard JP, Gandotra S, Ghamande SA, Gibbs KW, Herbert JT, Hughes CG, Janz DR, Joffe AM, Khan A, Kramer PJ, Latimer AJ, Mitchell SH, Moskowitz AL, Page DB, Prekker ME, Resnick-Ault D, Self WH, Smith LM, Sottile PD, Stempek SB, Trent SA, Vonderhaar DJ, Walker JE, White HD, Semler MW, Casey JD, Schauer SG, Ginde AA. Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. Am J Respir Crit Care Med. 2026 Aug 01; 212(8):1740-1749.
-
Horowitz M, Lamberson N, Brandt J, Framer A, Shapiro B, Sørensen A, Cadogan C, Ritvo A, Taylor D. Pharmacological principles for safe benzodiazepine and Z-drug dose reduction. Psychol Med. 2026 Jun 18; 56:e198.
-
Connery L, Rosenstock J, Rasouli N, Cheng AYY, Liebl A, Wang Q, Pires V, Knights A, Davidson MB, Child CJ. Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed-Dose Titration of Weekly Insulin Efsitora in Insulin-Naïve Type 2 Diabetes. Diabetes Obes Metab. 2026 Jul; 28(7):6217-6224.
-
Poonawala H, Davis K, Kenny ME, Alivisatos A, Van N, Washington T, Calado Nogueira de Moura V, Daley CL, Aldridge BB. Antibiotic dose-response curves can measure antibiotic activity against Mycobacterium abscessus and Mycobacterium peregrinum. Antimicrob Agents Chemother. 2026 05 06; 70(5):e0187625.
-
Alzate-Ricaurte S, Melkonian V, De La Torre L, Alzate Gallego ED, Ketzer J, Merritt A, Krause A, Peña A, Bischoff A. Longitudinal changes in senna-based laxative dosing in pediatric constipation: A single-center retrospective study. J Pediatr Surg. 2026 Jul; 61(7):163133.
-
Laux L, Sullivan J, Perry MS, Brunklaus A, Desurkar A, Schreiber JM, Roberts CM, Knupp KG, Wheless JW, Wirrell EC, Ventola P, Wang F, Lynch J, Parkerson KA, Ticho B, Cross JH. Zorevunersen in Children and Adolescents with Dravet Syndrome. N Engl J Med. 2026 Mar 05; 394(10):969-982.
-
Qadri N, Kwok E, Stanberry L, Thomas C, Irausquin SJ, Gupta D, Ebinger JE, Gluckman TJ, Mutharasan RK, Goyal A, Brownell NK, Scirica BM, Ho PM, Das SR, Downey W, Bradley SM. Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium. J Am Heart Assoc. 2026 Mar 17; 15(6):e038783.
-
Natsch A, Griem P, Irizar A, Bridges J, Vey M, Lee I, Api AM, Kern P, Kimber I. Derivation of a Point of Departure using NAMs for application in Quantitative Risk Assessment of fragrance materials. Regul Toxicol Pharmacol. 2026 May; 167:106052.
-
Ustianowski A, Levin MJ, De Wit S, Launay O, Veekmans B, Rampling T, Sullivan JG, Vishnepolsky M, Wijewardane P, Fawadleh Y, Zhang H, Li M, Wickramarachchi D, Sharbaugh A, Beavon R, Thissen J, Hirao L, Dzutseva V, Seegobin S, Streicher K, Kiazand A, Esser MT, Chang LJ, Perez JL, Cohen TS. Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-study. Clin Drug Investig. 2026 Feb; 46(2):207-219.
-
Moore CF, Bergeria CL, Sempio C, Klawitter J, Christians U, Weerts EM. High doses of orally administered cannabigerol produce deficits in sustained attention in female rats. Pharmacol Biochem Behav. 2026 Mar; 260:174154.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|